A multispectral 3D live organoid imaging platform to screen probes for fluorescence guided surgery

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

4 Citaten (Scopus)

Samenvatting

Achieving complete tumor resection is challenging and can be improved by real-time fluorescence-guided surgery with molecular-targeted probes. However, pre-clinical identification and validation of probes presents a lengthy process that is traditionally performed in animal models and further hampered by inter- and intra-tumoral heterogeneity in target expression. To screen multiple probes at patient scale, we developed a multispectral real-time 3D imaging platform that implements organoid technology to effectively model patient tumor heterogeneity and, importantly, healthy human tissue binding.

Originele taal-2Engels
Pagina's (van-tot)1495-1514
Aantal pagina's20
TijdschriftEMBO molecular medicine
Volume16
Nummer van het tijdschrift7
DOI's
StatusGepubliceerd - 15 jul. 2024

Vingerafdruk

Duik in de onderzoeksthema's van 'A multispectral 3D live organoid imaging platform to screen probes for fluorescence guided surgery'. Samen vormen ze een unieke vingerafdruk.

Citeer dit